Financial toxicity of hematologic malignancy therapies: Subjective experience of patients and impact on access to care. Receipt of financial drug assistance for oral targeted therapy among older ...

By Dr. Priyom Bose, Ph.D. While most women still choose clinic-based screening, new national data reveal that those who ...